Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective September 13, 2021, the Board of Directors ("Board") of Predictive
Oncology Inc. (the "Company") elected Raymond F. Vennare to the Board. He was
chosen to fill the vacancy created by the resignation of Richard Gabriel in May
2021. As a Class III Director, Mr. Vennare's term will expire at the 2021 annual
meeting of the Company's stockholders.
Mr. Vennare brings more than thirty years of experience to his work as an
accomplished senior executive, board director and biotechnology entrepreneur. As
a professional who has built and managed companies on behalf of institutional
investors, private foundations and research institutions, he is recognized as an
expert in the practice of company creation, technology commercialization,
business development and corporate governance. Mr. Vennare is currently (and has
been since 2015), Chairman of the Board and CEO of Cvergenx, Inc., a genomic
informatics company developing decision-support tools for radiation oncology,
and since 2019 has been on the Board of Directors of Cvergenx Technologies India
Private, Ltd. He also serves as a trusted and confidential advisor to clients as
diverse as nationally ranked universities and philanthropic foundations to
multi-national publicly traded companies and early-stage start-ups. Previously
Mr. Vennare was Co-founder, President and CEO of ThermalTherapeutic Systems,
Inc. (Medical Device); President and Chief Executive Officer of ImmunoSite, Inc.
(Diagnostics); Senior Vice President and Chief Information Officer,
TissueInformatics, Inc. (Bioinformatics); Founder, President and Partner in
VSInteractive (Information Technology) and, Founder and President of the Fine
Art Inventory Network (On-line Commerce). From June 2018 to December 2020, he
was Vice Chairman of Guangzhou INDA Biotechnology Company, Ltd.
Mr. Vennare has a Master's Degree in Business and Ethics from Duquesne
University; a Master's Degree in Art History and Museum Studies from Case
Western Reserve University and a Bachelor's Degree from the University of
Pittsburgh.
In recognition of the services Mr. Vennare will provide to the Company as a
member of the Board, he was issued 5,000 shares of common stock from the
Company's Amended and Restated 2012 Stock Incentive Plan simultaneously with his
election.
A press release announcing the appointment of the new director is attached
hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
99.1 Press Release dated September 15, 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses